Redenlab is the industry leading specialised CRO focussed on speech, language and swallowing endpoints. We use speech and language biometrics to improve decision-making in clinical trials. Whether the trials take place in clinic, at home, or virtually, our tests are sensitive and reliable, accurately detecting subtle changes caused by disease or treatment. Our speech software and hardware solutions meet all the regulatory requirements for data security and integrity in clinical trials, including 21 CFR Part 11 and HIPAA. Follow us to find out more about our groundbreaking projects and explore the future of meaningful measurement in clinical trials at www.redenlab.com.
| Website | http://redenlab.com |
| Employees | 31 (21 on RocketReach) |
| Founded | 2017 |
| Address | 585 Collins St, 669, Melbourne, Victoria 3000, AU |
| Technologies |
JavaScript
,
HTML
,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Neuroscience Technology, Clinical Trial Technology, Clinical Trials, Biometric Data Analysis, Clinical Trial Software, Virtual Clinical Trials, Speech Analysis, Healthcare Technology, Medical Technology, Remote Patient Monitoring, Language Processing, Digital Health, Biometric Authentication, Data Analytics, Healthcare Analytics, Biotechnology |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, GSK, AstraZeneca, Bristol Myers Squibb, Biogen, Eisai Co., Ltd. +44 more (view full list) |
Looking for a particular Redenlab employee's phone or email?
Adam Vogel is the CEO of Redenlab.
21 people are employed at Redenlab.
Redenlab is based in Melbourne, Victoria.